Insilico Medicine vs New Relic
Relationship
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
Aligned comparison
Capability overlap
Shared · 3
Not verified for New Relic · 5
Recorded for Insilico Medicine. New Relic’s product records say nothing either way — a missing record is not a missing capability.
New Relic has no capability Insilico Medicine lacks, among the 3 recorded here.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
New Relic
Application
New Relic AI analyzes telemetry data and answers questions about monitored systems.
New Relic Applied Intelligence detects anomalies and helps engineers understand and resolve incidents.
Platform
Observability for AI applications: LLM performance, error and cost, token and quality metrics, MCP server call lifecycle, and maps of multi-agent interactions.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for New Relic yet — nothing on the other side to compare them against.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
New Relic sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
AI agent
New Relic Autopilot investigates incidents, identifies likely root causes and recommends next actions.
Data service
New Relic Ground Truth combines telemetry, dependencies, incidents and changes into operational context for AI agents.